SEC Form 4 · accession 0001209191-15-072846
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Richard Reis
Director
Period of report
Oct 1, 2015
Accepted (ET)
Oct 1, 2015 · 6:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 1, 2015 | M | 5,000 | $2.24 | A | 35,000 | D | |
| Common Stock | Oct 1, 2015 | M | 15,000 | $2.24 | A | 50,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.24 | Oct 1, 2015 | M | 5,000 | D | — | Oct 31, 2019 | Common Stock | 5,000 | 0 | D |
| Employee Stock Option (right to buy)F1 | $2.24 | Oct 1, 2015 | M | 15,000 | D | — | Dec 31, 2019 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option is fully exercisable as of the date hereof.